Calendrier des promotions Forte Biosciences, Inc.
Calendrier avancé
Graphique simple
À propos de l'entreprise Forte Biosciences, Inc.
Forte Biosciences, Inc. operates as a biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.Paramètres de base
IPO date
2017-04-13
ISIN
US34962G1094
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
Grade
Sous-estimation
Nom | Signification | Grade |
P/S | 0 | 0 |
P/BV | 1.17 | 9 |
P/E | 0 | 0 |
Efficacité
Nom | Signification | Grade |
ROA | -70.57 | 0 |
ROE | -80.82 | 0 |
ROIC | 0 | 0 |
Dividendes
Nom | Signification | Grade |
Rendement en dividendes | 0 | 0 |
DSI | 0 | 0 |
Croissance moyenne du dividende | 0 | 0 |
Devoir
Nom | Signification | Grade |
Debt/EBITDA | 0 | 10 |
Debt/Ratio | 0 | 10 |
Debt/Equity | 0.173 | 10 |
Impulsion de croissance
Nom | Signification | Grade |
Rentabilité Revenue, % | -29.41 | 0 |
Rentabilité Ebitda, % | -297.98 | 0 |
Rentabilité EPS, % | 14.03 | 3 |
paper.price.prices
Prix | Common.min. | Common.max. | Changement | paper.changes_in_industry | paper.changes_in_index | |
common.calendar.number_days.1 | 12.09 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
common.calendar.number_days.7d | 12.61 $ | 0 $ | 0 $ | -4.13 % | 0 % | 0 % |
common.calendar.number_days.30d | 8.49 $ | 11.32 $ | 12.6 $ | 42.34 % | 0 % | 0 % |
common.calendar.number_days.90d | 5.25 $ | 5.25 $ | 12.6 $ | 130.19 % | 0 % | 0 % |
common.calendar.number_days.180d | 11.91 $ | 5.25 $ | 20.77 $ | 1.47 % | 0 % | 0 % |
common.calendar.number_days.1y | 7.73 $ | 0.3 $ | 28 $ | 56.34 % | 0 % | 0 % |
common.calendar.number_days.3y | 1.31 $ | 0.3 $ | 28 $ | 822.52 % | 0 % | 0 % |
common.calendar.number_days.5y | 18.92 $ | 0.3 $ | 50.69 $ | -36.13 % | 0 % | 0 % |
common.calendar.number_days.10y | 0.3 $ | 0.3 $ | 50.69 $ | 4028.33 % | 0 % | 0 % |
common.calendar.number_days.ytd | 14.97 $ | 5.25 $ | 25.27 $ | -19.27 % | 0 % | 0 % |
Principaux propriétaires
Entreprises similaires
P/E & P/BV
Gestion d'entreprise
Superviseur | Titre d'emploi | Paiement | Année de naissance |
Dr. Paul A. Wagner Ph.D. | CEO, President & Chairman | 960.23k | 1970 (55 années) |
Mr. Christopher Roenfeldt | Chief Operating Officer | N/A | |
Mr. Steven Ruhl | Chief Technical Officer | N/A | 1957 (68 années) |
Mr. Antony A. Riley CPA | Chief Financial Officer | 568.48k | 1967 (58 années) |
Dr. Barbara K. Finck M.D. | Chief Medical Clinician & Director | 45k | 1947 (78 années) |
Informations sur l'entreprise
Adresse: United States, Dallas. TX, 3060 Pegasus Park Drive - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.fortebiorx.com
Site web: https://www.fortebiorx.com